pyrimethamine has been researched along with Syndrome in 8 studies
Maloprim: contains above 2 cpds
Syndrome: A characteristic symptom complex.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Noble, A | 1 |
| MacDonald, A | 1 |
| Grayson, ML | 1 |
| Yung, AP | 1 |
| Doherty, RR | 1 |
| Adam, I | 1 |
| Elbashir, MI | 1 |
| Manenti, F | 1 |
| Porta, E | 1 |
| Esposito, R | 1 |
| Antinori, S | 1 |
| van der Werff ten Bosch, JE | 1 |
| Demanet, C | 2 |
| Balduck, N | 1 |
| Bakkus, MH | 1 |
| De Raeve, H | 1 |
| Desprechins, B | 1 |
| Otten, J | 2 |
| Thielemans, K | 2 |
| van der Werff Ten Bosch, J | 1 |
| Schotte, P | 1 |
| Ferster, A | 1 |
| Azzi, N | 1 |
| Boehler, T | 1 |
| Laurey, G | 1 |
| Arola, M | 1 |
| Beyaert, R | 1 |
| Danilevicius, Z | 1 |
| Dvorák, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pilot Study of Pyrimethamine and Sulfadoxine (Fansidar) for the Treatment of Individuals With the Autoimmune Lymphoproliferative Syndrome (ALPS)[NCT00013689] | Phase 1 | 8 participants | Interventional | 2001-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 other studies available for pyrimethamine and Syndrome
| Article | Year |
|---|---|
Drug-induced hepatotoxicity.
Topics: Antimalarials; Chemical and Drug Induced Liver Injury; Dapsone; Drug Combinations; Drug Eruptions; H | 1996 |
Severe dapsone syndrome due to weekly maloprim.
Topics: Adult; Antimalarials; Dapsone; Drug Combinations; Drug Eruptions; Female; Humans; Lymphatic Diseases | 1988 |
Extrapyramidal syndrome after treatment of falciparum malaria with sulphadoxine-pyrimethamine.
Topics: Adult; Animals; Antimalarials; Basal Ganglia Diseases; Drug Hypersensitivity; Drug Therapy, Combinat | 2004 |
Treatment of hyperreactive malarial splenomegaly syndrome.
Topics: Adult; Female; Humans; Leucovorin; Malaria, Falciparum; Male; Pyrimethamine; Splenomegaly; Syndrome | 1994 |
The use of the anti-malaria drug Fansidar (pyrimethamine and sulphadoxine) in the treatment of a patient with autoimmune lymphoproliferative syndrome and Fas deficiency.
Topics: Antimalarials; Autoimmune Diseases; Drug Combinations; fas Receptor; Humans; Infant; Lymphoprolifera | 1998 |
Reversion of autoimmune lymphoproliferative syndrome with an antimalarial drug: preliminary results of a clinical cohort study and molecular observations.
Topics: Adolescent; Antimalarials; Apoptosis; Autoimmune Diseases; Case-Control Studies; Caspase 3; Caspases | 2002 |
Editorial: A call to recognize PCP.
Topics: Alkanesulfonates; Amidines; Biopsy; Child; Developing Countries; Drug Therapy, Combination; Humans; | 1975 |
[Piringer-Kuchinka lymphadenitis cerviconuchalis: diagnosis and treatment].
Topics: Anti-Bacterial Agents; Humans; Lymphadenitis; Male; Neck; Pyrimethamine; Sulfanilamides; Syndrome; T | 1975 |